Skip to content
Deals

General Catalyst's Customer Value Fund provides $200m growth financing to Hone Health

The wider $228 million financing also includes a $28 million Series A extension led by MarcyPen Capital Partners, bringing Hone’s total equity funding to $65 million.

Alex Price2 min read

Share

About the deal

Borrower
Hone Health
Amount
$200m
Facility
RBF
Lender
General Catalyst Customer Value Fund
Equity investors
MarcyPen Capital Partners, Pentland Ventures, Kinship Ventures, Hanwha, Gannet Capital, humbition, Comma Capital, ID Ventures
Sector
Healthtech & Medtech
Region
North America
Country
United States
Announced

General Catalyst's Customer Value Fund (CVF) has provided $200 million of growth financing to Hone Health as part of a $228 million financing the company announced on 18 November 2026.

The financing also includes $28 million of equity structured as a Series A extension led by MarcyPen Capital Partners (MarcyPen). Other equity participants included Pentland Ventures, Kinship Ventures, Hanwha, Gannet Capital, humbition, Comma Capital and ID Ventures, alongside additional strategic investors.

Hone said MarcyPen has been a partner to the company for more than two years, having led its Series A financing, a role that had not previously been disclosed, and continued to back the company through follow-on investments. The new financing follows Hone's $33 million Series A, announced in January 2025, which supported its expansion beyond hormone health optimisation into broader longevity care.

CVF pays for a company's customer acquisition and is repaid from the revenue those new customers generate, with General Catalyst taking its return from the results of the sales and marketing spend it covers. Hone's announcement did not disclose the tenor, pricing, security, warrants or repayment terms of the $200 million CVF facility.

The company said the funding will support new clinical pathways and AI-enabled technology that turns patient data into physician-directed care. It plans to use the capital across broader clinical care, advanced diagnostics, clinical technology, a physician-supervised peptide programme, and research and trials. Hone also plans to publicly launch Hone Black, a concierge membership that has operated in stealth.

In a statement, Saad Alam, co-founder and chief executive of Hone Health, said, "Hone combines comprehensive diagnostic testing, physician-led care, and AI-powered insights to deliver that level of understanding. This funding will allow us to extend that vision across new therapeutic categories and start building toward our ultimate vision: a research platform to accelerate health outcomes."

Hone Health is a physician-led longevity platform that helps patients build personalised plans for health and longevity. Its care model is powered by Longevity OS, an AI clinical platform. The company said it has treated more than 200,000 patients, administered 750,000 tests and processed 25 million health markers.

The Stack

Venture debt and growth credit intelligence, in your inbox once a fortnight.

By subscribing, you agree to our Privacy Policy.